Richard Jaenisch and Christopher Cole discuss AI in pharma manufacturing, covering learning steps, output evaluation, hallucinations, and FDA/EMA guiding principles.
Laboratory testing validates low migration, low odor, and low VOC in clean, sustainable secondary packaging. Even paperboard ...
This week, PharmTech took a look at the shift toward proactive, data-driven contamination control, the adoption of advanced material science to solve manufacturing hurdles, and an ...
PRAC-triggered post-authorization actions for cenobamate will cascade across SmPC, PIL, and controlled regulatory materials, ...
As a part of PDA Week 2026, Christopher Lewis, Emoja Biopharma and President of the Mountain States PDA Chapter, sat down ...
Legacy web forms used for clinical trial recruitment, adverse event reporting, laboratory data collection, and regulatory ...
On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...
Digital twins function as synchronized, real-time operational mirrors, where divergence from the physical process triggers ...
VP of operations and support at Kiteworks, with more than 20 years of experience in IT support and services. Since joining ...
The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results